SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-035508
Filing Date
2020-08-03
Accepted
2020-08-03 16:12:01
Documents
76
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q adro-10q_20200630.htm   iXBRL 10-Q 3364155
2 EX-31.1 adro-ex311_10.htm EX-31.1 17198
3 EX-31.2 adro-ex312_7.htm EX-31.2 17144
4 EX-32.1 adro-ex321_6.htm EX-32.1 8148
  Complete submission text file 0001564590-20-035508.txt   10888652

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA adro-20200630.xsd EX-101.SCH 62005
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adro-20200630_cal.xml EX-101.CAL 71116
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adro-20200630_def.xml EX-101.DEF 201705
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE adro-20200630_lab.xml EX-101.LAB 503261
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adro-20200630_pre.xml EX-101.PRE 379124
10 EXTRACTED XBRL INSTANCE DOCUMENT adro-10q_20200630_htm.xml XML 2139618
Mailing Address 740 HEINZ AVENUE BERKELEY CA 94710
Business Address 740 HEINZ AVENUE BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37345 | Film No.: 201069359
SIC: 2834 Pharmaceutical Preparations